OTC - ACTIVE INGREDIENT SECTION
Active Ingredient
White Petrolatum USP 91.7%
Light Mineral Oil NF 1.4%
Active Ingredient
White Petrolatum USP 91.7%
Light Mineral Oil NF 1.4%
Inactive Ingredient
Lanolin USP 6.9%
Purpose: Active Ingredient
White Petrolatum USP 91.7% . . . . . .Purpose: Eye Protectant
Light Mineral Oil NF 1.4% . . . . . . . . .Purpose: Lubricant
Warnings
For use in the eye
Uses:
When using this product
Stop use and ask a Doctor if
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
Other Information:
Store at 46°–80°F (8°–27°C)
Do not use if the tamper-evident seal is broken or missing
Questions?
support@noveha.com
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 5060643132884 | GTIN-13: 5060643132884 EAN-13: 5060643132884 GTIN storage (14 digits): 05060643132884 | NOVEHA OINTMENT LABEL.jpg |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84008-004-02 | NOVEHA NIGHTTIME | 1 in 1 BOX | GEL | 1 | 2 | |
| 84008-004-02 | NOVEHA NIGHTTIME | 10 g in 1 TUBE | GEL | 10 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 84008-004 | 84008-004-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LANOLIN | 7EV65EAW6H | IACT |
| LIGHT MINERAL OIL | N6K5787QVP | ACTIB |
| WHITE PETROLATUM | B6E5W8RQJ4 | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NOVEHA NIGHTTIME | WHITE PETROLATUM | Bullet Point LLC | 4da24578-e98b-8ce1-e063-6294a90a8bf6 | 2026-03-24 | Warnings | 84008-004-02 84008-004 84008000402 4dc9e07d-8f98-c05b-e063-6394a90a5b3f 4da24578-e98b-8ce1-e063-6294a90a8bf6 |
Adverse event summaries are temporarily unavailable. Other product information remains available.